Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 332

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

International working group on Sarcopenia

Open access
Chumlea, WM. C., Cesari, M., Evans, W.J., Ferrucci, L., Fielding, R.A., Pahor, M., Studenski, S., Vellas, B.·2011·The Journal of nutrition, health and aging
DOI 10.1007/s12603-011-0092-7
Open this paper in CoChat — free account

Abstract

Sarcopenia is the age-related involuntary loss of skeletal muscle mass and functionality that can lead to the development of disability, frailty and increased health care costs. The development of interventions aimed at preventing and/or treating sarcopenia is complex, requiring the adoption of assumptions and standards that are not well established scientifically or clinically. A number of investigators and clinicians (both from academia and industry) met in Rome (Italy) in 2009 to develop a consensus definition of sarcopenia. Subsequently, in Albuquerque (New Mexico, USA) in 2010, the same group met again to consider the complex issues necessary for designing Phase II clinical trials for sarcopenia. Current clinical trial data indicate that fat-free mass (FFM) parameters are responsive to physical activity/nutritional treatment modalities over short time periods, but pharmacological trials of sarcopenia have yet to show significant efficacy. In order to conduct a clinical trial within a reasonable time frame, groups that model or display accelerated aging and loss of FFM are necessary. Few studies have used acceptable designs for testing treatment effects, sample sizes or primary outcomes that could provide interpretable findings or effects across studies. Dual energy x-ray absorptiometry (DXA) is the measure of choice for assessing FFM, but sufficient time is needed for changes to be detected accurately and reliably. A tool set that would allow clinical, basic and epidemiological research on sarcopenia to advance rapidly toward diagnosis and treatment phases should be those reflecting function and strength.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12603-011-0092-7

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 66

  1. Evans, 1995, What is Sarcopenia?, J Gerontol, 50A, 5, 10.1093/gerona/50A.Special_Issue.5 · DOI · Paper page
  2. Lang, 2010, Sarcopenia: etiology, clinical consequences, intervention, and assessment, Osteoporos Int, 21, 543, 10.1007/s00198-009-1059-y · DOI · Paper page
  3. Thomas, 2010, Sarcopenia, Clin Geriatr Med, 26, 331, 10.1016/j.cger.2010.02.012 · DOI
  4. Jones, 2009, Sarcopenia—mechanisms and treatments, J Geriatr Phys Ther, 32, 83, 10.1519/00139143-200932020-00008 · DOI
  5. Morley, 2001, Anorexia, sarcopenia, and aging, Nutrition, 17, 660, 10.1016/S0899-9007(01)00574-3 · DOI · Paper page
  6. Rolland, 2008, Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives, J Nutr Health Aging, 12, 433, 10.1007/BF02982704 · DOI · Paper page
  7. Larsson, 1978, Morphological and functional characteristics of the aging skeletal muscle in man, Acta Physiol Scand Suppl, 457, 1
  8. Larsson, 1983, Histochemical characteristics of human skeletal muscle during aging, Acat Physiol Scand, 117, 469, 10.1111/j.1748-1716.1983.tb00024.x · DOI · Paper page
  9. Larsson, 1978, Morphological and functional characteristics of the ageing skeletal muscle in man. A cross-sectional study, Acta Physiol Scand Suppl, 457, 1
  10. Larsson, 1983, Histochemical characteristics of human skeletal muscle during aging, Acta Physiol Scand, 117, 469, 10.1111/j.1748-1716.1983.tb00024.x · DOI · Paper page
  11. Verdijk, 2010, Characteristics of muscle fiber type are predictive of skeletal muscle mass and strength in elderly men, J Am Geriatr Soc, 58, 2069, 10.1111/j.1532-5415.2010.03150.x · DOI
  12. Weber, 2010, [Sarcopenia: a physical marker of frailty], Rev Med Liege, 65, 514
  13. Welle, 2003, Gene expression profile of aging in human muscle, Physiol Genomics, 14, 149, 10.1152/physiolgenomics.00049.2003 · DOI · Paper page
  14. Carey, 2007, Impaired expression of Notch signaling genes in aged human skeletal muscle, J Gerontol A Biol Sci Med Sci, 62, 9, 10.1093/gerona/62.1.9 · DOI
  15. Schrager, 2004, Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span, J Appl Physiol, 97, 2176, 10.1152/japplphysiol.00985.2003 · DOI
  16. Chapman, 2002, The anorexia of ageing, Biogerontology, 3, 67, 10.1023/A:1015211530695 · DOI
  17. Volpi, 2001, Basal muscle amino acid kinetics and protein synthesis in healthy young and older men, JAMA, 286, 1206, 10.1001/jama.286.10.1206 · DOI · Paper page
  18. Katsanos, 2005, Aging is associated with diminished accretion of muscle proteins after the ingestion of a small bolus of essential amino acids, Am J Clin Nutr, 82, 1065, 10.1093/ajcn/82.5.1065 · DOI · Paper page
  19. Campbell, 1994, Increased protein requirements in elderly people: new data and retrospective reassessments, Am J Clin Nutr, 60, 501, 10.1093/ajcn/60.4.501 · DOI · Paper page
  20. Campbell, 2001, The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle, J Gerontol A Biol Sci Med Sci, 56, M373, 10.1093/gerona/56.6.M373 · DOI · Paper page
  21. Visser, 2003, Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam, J Clin Endocrinol Metab, 88, 5766, 10.1210/jc.2003-030604 · DOI · Paper page
  22. Kuh, 2005, Grip strength, postural control, and functional leg power in a representative cohort of British men and women: associations with physical activity, health status, and socioeconomic conditions, Journals of Gerontology Series A-Biological Sciences & Medical Sciences, 60, 224, 10.1093/gerona/60.2.224 · DOI · Paper page
  23. Hughes, 2004, Anthropometric assessment of 10-y changes in body composition in the elderly, Am J Clin Nutr, 80, 475, 10.1093/ajcn/80.2.475 · DOI · Paper page
  24. Morley, 2003, Hormones and the aging process, J Am Geriatr Soc, 51, S333, 10.1046/j.1365-2389.2003.51344.x · DOI
  25. Guillet, 2005, Insulin resistance: a contributing factor to age-related muscle mass loss?, Diabetes Metab 31 Spec No, 2, 5S20
  26. Park, 2006, Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study, Diabetes, 55, 1813, 10.2337/db05-1183 · DOI · Paper page
  27. McDermott, 2001, Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment, JAMA, 286, 1599, 10.1001/jama.286.13.1599 · DOI · Paper page
  28. McDermott, 2004, Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: the InCHIANTI Study, J Am Geriatr Soc, 52, 405, 10.1111/j.1532-5415.2004.52113.x · DOI · Paper page
  29. McDermott, 2007, Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial disease, J Vasc Surg, 46, 87, 10.1016/j.jvs.2007.02.064 · DOI
  30. Ferrucci, 2002, Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels, J Am Geriatr Soc, 50, 1947, 10.1046/j.1532-5415.2002.50605.x · DOI · Paper page
  31. Morley, 2001, Sarcopenia, J Lab Clin Med, 137, 231, 10.1067/mlc.2001.113504 · DOI · Paper page
  32. Castillo, 2003, Sarcopenia in elderly men and women: the Rancho Bernardo study, Am J Prev Med, 25, 226, 10.1016/S0749-3797(03)00197-1 · DOI · Paper page
  33. Gillette-Guyonnet, 2003, Body composition in French women 75+ years of age: the EPIDOS study, Mech Ageing Dev, 124, 311, 10.1016/S0047-6374(02)00198-7 · DOI
  34. Tanko, 2002, Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women, Metabolism, 51, 69, 10.1053/meta.2002.28960 · DOI
  35. Melton, 2000, Epidemiology of sarcopenia, Journal of the American Geriatrics Society, 48, 625, 10.1111/j.1532-5415.2000.tb04719.x · DOI · Paper page
  36. Rolland, 2009, [Sarcopenia], Rev Med Interne, 30, 150, 10.1016/j.revmed.2008.08.013 · DOI
  37. Morley, 2005, Frailty and the aging male, Aging Male, 8, 135, 10.1080/13685530500277232 · DOI
  38. Abellan Van Kan G, Chumlea WC, Gillette-Guyonnet S et al (2011). Clinical trials on sarcopenia - Methodological issues regarding Phase III trials. Clin Trials Geriatr Med: In press. · DOI
  39. Sakuma, 2010, Molecular mechanisms in aging and current strategies to counteract sarcopenia, Curr Aging Sci, 3, 90, 10.2174/1874609811003020090 · DOI
  40. Park, 2010, Yearlong physical activity and sarcopenia in older adults: the Nakanojo Study, European Journal of Applied Physiology, 109, 953, 10.1007/s00421-010-1424-8 · DOI
  41. Hanson, 2009, Effects of strength training on physical function: influence of power, strength, and body composition, J Strength Cond Res, 23, 2627, 10.1519/JSC.0b013e3181b2297b · DOI
  42. Kemmler, 2010, Exercise, body composition, and functional ability: a randomized controlled trial, Am J Prev Med, 38, 279, 10.1016/j.amepre.2009.10.042 · DOI
  43. Phillips, 2010, Interruption of physical activity because of illness in the Lifestyle Interventions and Independence for Elders Pilot trial, J Aging Phys Act, 18, 61, 10.1123/japa.18.1.61 · DOI
  44. Cornish, 2009, Alpha-linolenic acid supplementation and resistance training in older adults, Appl Physiol Nutr Metab, 34, 49, 10.1139/H08-136 · DOI
  45. Riechman, 2007, Statins and dietary and serum cholesterol are associated with increased lean mass following resistance training, J Gerontol A Biol Sci Med Sci, 62, 1164, 10.1093/gerona/62.10.1164 · DOI
  46. Solerte, 2008, Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia, Am J Cardiol, 101, 69E, 10.1016/j.amjcard.2008.03.004 · DOI · Paper page
  47. Symons, 2009, A moderate serving of high-quality protein maximally stimulates skeletal muscle protein synthesis in young and elderly subjects, J Am Dietet Assn, 109, 1582, 10.1016/j.jada.2009.06.369 · DOI · Paper page
  48. Zak, 2009, Combined effects of functionally-oriented exercise regimens and nutritional supplementation on both the institutionalised and free-living frail elderly (double-blind, randomised clinical trial), BMC Public Health, 9, 39, 10.1186/1471-2458-9-39 · DOI
  49. Smith, 2011, Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial, Am J Clin Nutr, 93, 402, 10.3945/ajcn.110.005611 · DOI · Paper page
  50. Campbell, 2007, Dietary protein and resistance training effects on muscle and body composition in older persons, J Am Coll Nutr, 26, 696S, 10.1080/07315724.2007.10719650 · DOI · Paper page
  51. Atkinson, 2010, Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly men, J Gerontol A Biol Sci Med Sci, 65, 1215, 10.1093/gerona/glq118 · DOI
  52. Blackman, 2002, Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial, J Am Med Assn, 288, 2282, 10.1001/jama.288.18.2282 · DOI · Paper page
  53. Jacobsen, 2010, Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial, Eur J Endocrinol, 162, 371, 10.1530/EJE-09-0619 · DOI
  54. Giannoulis, 2008, The effects of growth hormone and/or testosterone on whole body protein kinetics and skeletal muscle gene expression in healthy elderly men: a randomized controlled trial, J Clin Endocrinol Metab, 93, 3066, 10.1210/jc.2007-2695 · DOI
  55. Cesari, 2008, Target population for clinical trials on sarcopenia, J Nutr Health Aging, 12, 470, 10.1007/BF02982708 · DOI
  56. Litaker, 2003, Comparison of Hologic QDR-1000/W and 4500W DXA Scanners in 13- to 18-Year Olds, Obes Res, 11, 1545, 10.1038/oby.2003.206 · DOI
  57. Lohman, 2009, Reproducibility of dualenergy x-ray absorptiometry total and regional body composition measurements using different scanning positions and definitions of regions, Metabolism, 58, 1663, 10.1016/j.metabol.2009.05.023 · DOI
  58. Schoeller, 2005, QDR 4500A dual X-ray absorptiometer underestimates fat mass in comparison with criterion methods in adults, Am J Clin Nutr, 8, 1018, 10.1093/ajcn/81.5.1018 · DOI · Paper page
  59. Waters, 2010, Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update, Clin Interv Aging, 5, 259, 10.2147/CIA.S6920 · DOI
  60. Chale-Rush, 2010, Relationship between physical functioning and physical activity in the lifestyle interventions and independence for elders pilot, J Am Geriatr Soc, 58, 1918, 10.1111/j.1532-5415.2010.03008.x · DOI
  61. Critchley M (1931). The neurology of old age. Lancet: 1221–1230. · DOI
  62. Forbes, 1976, The Adult Decline in Lean Body Mass, Hum Biol, 48, 161
  63. Lesser, 1963, Changes in Body Composition with Age, Ann N Y Acad Sci, 110, 578, 10.1111/j.1749-6632.1963.tb15781.x · DOI
  64. Moore, 1963, Body Cell Mass and Limits of Hydration of the Fat-Free Body: Their Relation to Estimated Skeletal Weight, Ann N Y Acad Sci, 110, 62, 10.1111/j.1749-6632.1963.tb17072.x · DOI
  65. Norris, 1963, Trends in Selected Indices of Body Composition in Men between the Ages 30 and 80 Years, Ann N Y Acad Sci, 110, 623, 10.1111/j.1749-6632.1963.tb15784.x · DOI
  66. Wessel, 1963, Age Trends of Various Components of Body Composition and Functional Characteristics in Women Aged 20–69 Years, Ann N Y Acad Sci, 110, 608, 10.1111/j.1749-6632.1963.tb15783.x · DOI

Cited by

Metadata

Authors
Chumlea, W. C., Cesari, M., Evans, W. J., Ferrucci, L., Fielding, R. A., Pahor, M., Studenski, S., & Vellas, B.
Venue
The Journal of nutrition, health and aging
Publisher
Elsevier BV
Published
2011-06
Volume
15
Issue
6
Pages
450-455
ISSN
1279-7707 (ISSN-L)
DOI
10.1007/s12603-011-0092-7
OpenAlex
W1997149183
Cited by
332
References
15
FWCI
42.37
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.